Status:
COMPLETED
Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Dutch Heart Foundation
Conditions:
Familial Hypercholesterolemia
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
This study evaluates plaque burden and characteristics in early-treated FH patients compared to late-treated FH patients and healthy individuals.
Eligibility Criteria
Inclusion
- Diagnosed with heterozygous familial hypercholesterolemia or non FH-control
- Adult patients between 25 and 55 years old.
Exclusion
- Renal insufficiency, defined as eGFR \< 30 ml/min
- Atrial fibrillation
- Any other treatment or clinically relevant condition that could interfere with the conduct or interpretation of the study in the opinion of the investigator
- Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2022
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT05352386
Start Date
March 7 2022
End Date
December 19 2022
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, location AMC
Amsterdam, Netherlands